Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Reexamination Certificate
2006-06-06
2006-06-06
Kim, Vickie (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
C424S487000, C424S200100, C424S200100, C424S001210, C424S001210, C514S772100, C514S944000
Reexamination Certificate
active
07056533
ABSTRACT:
A coating composition, in both its uncrosslinked and crosslinked forms, for use in delivering a medicament from the surface of a medical device positioned in vivo. Once crosslinked, the coating composition provides a gel matrix adapted to contain the medicament in a form that permits the medicament to be released from the matrix in a prolonged, controlled, predictable and effective manner in vivo. A composition includes a polyether monomer, such as an alkoxy poly(alkylene glycol), a carboxylic acid-containing monomer, such as (meth)acrylic acid, a photoderivatized monomer, and a hydrophilic monomer such as acrylamide.
REFERENCES:
patent: 4107121 (1978-08-01), Stoy
patent: 4442133 (1984-04-01), Greco et al.
patent: 4655771 (1987-04-01), Wallsten
patent: 4733665 (1988-03-01), Palmaz
patent: 4800882 (1989-01-01), Gianturco
patent: 4886062 (1989-12-01), Wiktor
patent: 4895566 (1990-01-01), Lee
patent: 4917686 (1990-04-01), Bayston et al.
patent: 4952419 (1990-08-01), De Leon et al.
patent: 4954126 (1990-09-01), Wallsten
patent: 5002582 (1991-03-01), Guire et al.
patent: 5013306 (1991-05-01), Solomon et al.
patent: 5061275 (1991-10-01), Wallsten et al.
patent: 5443455 (1995-08-01), Hergenrother et al.
patent: 5556635 (1996-09-01), Istin et al.
patent: 5739210 (1998-04-01), Scranton et al.
patent: 5749837 (1998-05-01), Palermo et al.
patent: 5769796 (1998-06-01), Palermo et al.
patent: 5844039 (1998-12-01), Scranton et al.
patent: 5853745 (1998-12-01), Darouiche
patent: 5884039 (1999-03-01), Ludwig et al.
patent: 5997517 (1999-12-01), Whitbourne
patent: 6042875 (2000-03-01), Ding et al.
patent: WO 99/47129 (1999-09-01), None
patent: WO 99/47176 (1999-09-01), None
patent: WO 01/21326 (2001-03-01), None
C.L. Bell, and N. A. Peppas,J. Biomater. Sci. Polymer Edn. 7(8):671-683 (1996) and C.L. Bell.
Brzoska, J.B., et. al.,Langmuir 10:4367-4373, 1994.
N. A. Peppas,Biomaterials 17:1203-1218 (1996).
Scott, et al.,Biomaterials 20(15):1371-1380 (1999).
Mathur, et al.,J. Controlled Release 54(2):177-184 (1998).
Solomon, D. D. and Sherertz, R. J.,J. Controlled Release, 6:343-352 (1987).
Peppas N.A., et al., “Poly(ethylene Glycol)-Containing Hydrogels in Drug Delivery”,Journal of Controlled Release, Elsevier Science Publishers B.V., Amsterdam, NL, vol. 62, No. 1/2, (1999), pp. 81-87.
Amos Richard A.
Chudzik Stephen J.
Everson Terrence P.
Fredrikson & Byron , P.A.
Kim Vickie
SurModics, Inc.
LandOfFree
Medicament incorporation matrix does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicament incorporation matrix, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament incorporation matrix will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3630606